AG
EW icon

AlTi Global’s Edwards Lifesciences EW Stock Holding History

AlTi Global’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$470K Buy
5,191
+35
+0.7% +$2.93K 0.01% 371
2026
Q1 		$413K Buy
5,156
+104
+2% +$8.57K 0.01% 332
2025
Q4 		$431K Sell
5,052
-187
-4% -$15.3K 0.01% 328
2025
Q3 		$407K Buy
5,239
+247
+5% +$19.3K 0.01% 330
2025
Q2 		$390K Buy
4,992
+20
+0.4% +$1.49K 0.01% 326
2025
Q1 		$360K Sell
4,972
-826
-14% -$59.1K 0.01% 309
2024
Q4 		$428K Sell
5,798
-161
-3% -$11.3K 0.01% 302
2024
Q3 		$393K Sell
5,959
-366
-6% -$26.6K 0.01% 299
2024
Q2 		$584K Buy
6,325
+28
+0.4% +$2.48K 0.02% 244
2024
Q1 		$602K Buy
6,297
+857
+16% +$72K 0.02% 231
2023
Q4 		$415K Buy
+5,440
New +$379K 0.01% 259

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

AlTi Global's EW Position: Q2 2026 in Review

AlTi Global increased its Edwards Lifesciences (EW) stake by 0.68% in Q2 2026, buying an estimated $2.93K and bringing the position to 5,191 shares worth $470K. The position accounts for 0.01% of the portfolio, ranked #371.

AlTi Global first reported a position in EW in Q4 2023 and has held it in 11 quarters since. The position peaked at $602K in Q1 2024. 774 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • AlTi Global held 5,191 shares of Edwards Lifesciences worth $470K as of Q2 2026.
  • AlTi Global bought 35 Edwards Lifesciences shares in Q2 2026, an estimated $2.93K.
  • Edwards Lifesciences made up 0.01% of AlTi Global's portfolio in Q2 2026, its #371 holding.
  • AlTi Global first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 11 quarters since.
  • AlTi Global's Edwards Lifesciences position peaked at $602K in Q1 2024.
  • 774 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on AlTi Global's 13F filing for Q2 2026, filed 5 Aug 2026.